‹ ›
MYP_163441
← PREVIOUS NEXT → BACK
Basic Information
Unnamed
Antimicrobial
Antiviral
Antiviral ▸ Anti-Pneumovirus ▸ Anti-RSV
Antiviral ▸ Antiviral mechanism ▸ Viral entry inhibition
Antiviral ▸ Antiviral mechanism ▸ Viral replication inhibition ▸ Replication inhibitor
Standard
6 amino acids
C32H52N6O8S2
Standard
Sequence
ILMCFS
Physicochemical Analysis
712.92 Da
5.52
-0.25
-0.47
-0.0416
2.45
0.36
0.73
40.43
130.00
0.1667
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
229.05
-0.17
9.0
10.0
22.0
48.0
1.0
5.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0160204 VERIFIED: YES
Provenance & Taxonomy
not reported [other]
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral
PaperAVPdb: a database of experimentally validated antiviral peptides targeting medically important viruses PMID24285301 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/24285301/
RECORD: Rec_0211759 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral
respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells
50 μM
IC50
PaperPubMed PMID: 14576104 PMID14576104 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/14576104/
RECORD: Rec_0215742 VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
RhoA-derived
9606;0
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral Replication inhibitor
Respiratory syncytial virus (Replication); HEp-2
50 μM
Viral antigen reduction assay
PaperAntiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers. | Budge PJ, Lebowitz J, Graham BS. | Antimicrob Agents Chemother. 2003 | PMID:14576104 PMID14576104 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/14576104/
RECORD: Rec_0238869 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral
PaperPubMed PMID: 14576104 PMID14576104 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/14576104/
RECORD: Rec_0333731 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Protein-derived synthetic peptide
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Anti-RSV Entry inhibition
Respiratory syncytial virus (RSV) | HEp-2 cells
50 μM
IC50
Mammalian: 20 h; Yeast: 30 min; E. coli: >10 h
PaperAntiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers. | Budge PJ, Lebowitz J, Graham BS. | Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7. | DOI:10.1128/AAC.47.11.3470-3477.2003 | PMID:14576104 PMID14576104 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/14576104/